Global Hemostats and Tissue Sealants Market Research Report 2021

Blood clotting or coagulation, is an important process that eliminates excessive bleeding when a blood vessel is damaged. Platelets and proteins work together to stop the bleeding by forming a clot over the injury. Blood clottage is one of the mechanisms that reduce the loss of blood from damaged blood vessels. Hemostats and tissue sealants are used post-surgery or traumatic injury to bind or hold external tissue (skin) as well as internal tissue (blood vessels). Some key types of hemostats and tissue sealants include fibrin sealants, collagen-based compounds, synthetic agents, and tissue adhesive glues such as hydrogels and glutaraldehyde glues. Fibrin sealants have a wide range of medical applications.
The recent increase in number of out-patient surgeries is the prime driver for the growth of this market. Since these surgeries help to reduce the overall healthcare expenditure, they are increasingly being preferred by insurance payers to acquire reimbursements for their surgeries. Furthermore, as the out-patient surgeries do not require overnight stays, they are readily available to the patients.

The global Hemostats and Tissue Sealants market was valued at US$ 3178.1 million in 2019 and is expected to reach US$ 4800.3 million by the end of 2026, growing at a CAGR of 6.0% during 2021-2026.
This report focuses on Hemostats and Tissue Sealants volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Hemostats and Tissue Sealants market size by analysing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Asia-Pacific, Latin America and Middle East & Africa.

Global Hemostats and Tissue Sealants Market: Segment Analysis
The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth.

Segment by Type
Hemostats
Tissue Sealants

Segment by Application
Clinical Medicine
Scientific Research

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E

By Company
Baxter
CR Bard
Johnson & Johnson
B.Braun
Cardinal Health
Cryolife
Neomend
Vivostat
Z-Medica